Nephrectomy

Overview of Treatment

Nephrectomy is a surgical procedure used to remove part or all of the kidney, primarily for the treatment of renal diseases or tumors. This surgery can be classified into "radical nephrectomy" and "partial nephrectomy," depending on the extent of the lesion and the patient's condition. The main goal is to excise the diseased tissue to prevent the spread of malignant tumors or to address severe kidney damage.

In the treatment of kidney cancer, nephrectomy is often considered a definitive therapy; if the kidney is lost due to trauma, infection, or severe injury, surgery is the final solution. The surgical approach may be traditional open surgery or minimally invasive techniques, depending on the patient's physical condition and lesion location.

Types and Mechanisms of Treatment

Nephrectomy mainly falls into three types:

  • Open nephrectomy: Removal of the kidney through a large incision in the abdomen or flank, suitable for complex lesions or larger patients.
  • Laparoscopic nephrectomy: Using 3-4 small incisions to insert a camera and instruments, guided by imaging, resulting in less trauma.
  • Robot-assisted surgery: Combining laparoscopic techniques with robotic systems to enhance surgical precision, commonly used in complex partial nephrectomies.

The surgical mechanism involves locating the renal artery and vein, occluding blood flow, and then removing the target tissue while ensuring blood supply to the remaining renal tissue. Partial nephrectomy requires preserving healthy kidney tissue to maintain renal function.

Indications

Main indications include:

  • Malignant tumors: such as renal cell carcinoma and metastatic tumors.
  • Benign tumors: such as angiomyolipomas or enlarging renal cysts that threaten health.
  • Severe injury: kidney rupture due to accidents or trauma that cannot be repaired.
  • Others: such as severe polycystic kidney disease, recurrent infections, or kidney stones leading to loss of function.

In some cases, if one kidney is severely damaged but the other is functioning normally, the physician may recommend complete removal to prevent infection or deterioration.

Usage and Dosage

The procedure is usually performed under general anesthesia, with duration varying from 3-5 hours for radical nephrectomy and more complex for partial removal. Patients need to fast before surgery and undergo blood tests and imaging scans to assess tumor location.

Postoperative hospitalization typically lasts 5-10 days, with recovery taking about 4-6 weeks. The physician will adjust the surgical approach based on renal function, age, and comorbidities; for example, older patients may prefer minimally invasive techniques to reduce trauma.

Benefits and Advantages

Main benefits include:

  • Tumor eradication: directly removing malignant tissue to reduce metastasis risk.
  • Function preservation: partial nephrectomy can maintain residual renal filtration function.
  • Minimally invasive techniques reduce trauma: laparoscopic or robotic surgeries shorten recovery time.

Long-term follow-up shows that early-stage renal cancer patients who undergo curative nephrectomy have a 5-year survival rate of 70-90%. Additionally, minimally invasive techniques have a complication rate reduced by over 30% compared to traditional open surgery.

Risks and Side Effects

Potential risks include:

  • Intraoperative bleeding: especially if arteries or veins are damaged, requiring emergency management.
  • Infection: wound infection or urinary tract infection, treated with antibiotics.
  • Renal failure: complete removal may lead to chronic kidney disease if the contralateral kidney's function is insufficient.

Serious complications include: renal artery embolism, pulmonary embolism risks, or residual renal tissue dysfunction post-surgery. Elderly patients or those with diabetes may experience prolonged recovery and increased infection risks.

Precautions and Contraindications

Contraindications include:

  • Severe cardiopulmonary insufficiency unable to tolerate anesthesia.
  • Uncontrolled coagulopathy.
  • Severe contralateral kidney dysfunction, unable to compensate.

Postoperative monitoring of blood pressure and renal function is essential, along with avoiding strenuous activity for at least 6 weeks. Patients should follow medical instructions regarding pain management and antibiotics, and undergo regular urine and imaging follow-up.

Interactions with Other Treatments

This surgery is often combined with other therapies:

  • Preoperative chemotherapy: to shrink tumors for easier removal.
  • Postoperative radiotherapy: to eliminate residual cancer cells.
  • Targeted therapy: for advanced renal cancer, may be administered after surgery.

Attention should be paid to interactions between hemostatic drugs and anesthetics, such as temporarily stopping anticoagulants to reduce intraoperative bleeding risk. The physician will adjust anesthesia plans based on the patient's medication history.

Effectiveness and Evidence

Clinical studies indicate that early-stage renal cell carcinoma patients undergoing radical nephrectomy have a 5-year survival rate of 70-90%. Partial nephrectomy can preserve renal function, especially in patients with a healthy contralateral kidney, with long-term survival comparable to total removal.

The use of minimally invasive techniques reduces postoperative pain by 40% and shortens hospital stays to 5-7 days. Large studies show that robotic-assisted surgeries achieve a tumor margin clearance rate of up to 98%, with complication rates lower than traditional surgeries.

Alternatives

Non-surgical options include:

  • Radiofrequency Ablation (RFA): using high heat to destroy tumors, suitable for tumors smaller than 4 cm in diameter.
  • Active surveillance: for elderly or high-risk patients, regularly monitoring small tumors for changes.
  • Renal artery embolization: blocking tumor blood flow to control bleeding or reduce tumor size.

The choice of alternatives depends on tumor characteristics, overall health, and renal function. For example, patients with a single kidney may prioritize partial removal or ablation to avoid the risk of renal failure after total nephrectomy.

 

Frequently Asked Questions

What preoperative examinations are necessary?

Patients should undergo detailed imaging examinations (such as abdominal CT or MRI) to evaluate the location of the renal lesion and vascular distribution. Blood tests, cardiopulmonary assessments, and coagulation function tests are also necessary to assess suitability for surgery and reduce intraoperative risks.

How can postoperative urinary leakage be prevented and managed?

Urinary leakage is a potential complication after partial nephrectomy. Surgeons use suturing techniques and drainage tubes to reduce this risk. If postoperative drainage appears urine-like or if fever occurs, medical staff should be notified immediately. Imaging may be required for confirmation, and in severe cases, temporary placement of a double-J stent or reoperation may be necessary to adjust sutures.

How long after surgery can daily activities resume?

Traditional open surgery typically requires 5-7 days of hospitalization, while laparoscopic or robotic surgeries shorten this to 3-5 days. Generally, strenuous activities such as lifting heavy objects or vigorous exercise should be avoided for 4-6 weeks, but light activities like walking can gradually resume. The exact recovery time depends on the extent of removal and individual health, and should follow the physician's instructions.

Will the remaining kidney deteriorate faster after unilateral nephrectomy?

In healthy adults, the remaining kidney compensates by increasing filtration, usually not leading to acute renal failure. However, long-term, patients with chronic conditions (such as hypertension or diabetes) or older age should have regular renal function monitoring. Measures such as controlling blood pressure, a low-protein diet, and avoiding nephrotoxic drugs are recommended to protect the residual kidney.

When should follow-up examinations be conducted after surgery?

It is recommended to perform renal function tests, abdominal imaging, and tumor marker assessments every 3-6 months in the first year. For patients treated for tumor removal, follow-up frequency should be adjusted according to cancer staging; high-risk patients may require more frequent PET-CT scans. Long-term follow-up can facilitate early detection of recurrence or second primary tumors.